Clinical Evaluation of the Adult with Eosinophilic Esophagitis.
Endoscopic signs
Eosinophilic esophagitis
Histologic findings
Laboratory abnormalities
Physical examination
Treatment modalities
Journal
Immunology and allergy clinics of North America
ISSN: 1557-8607
Titre abrégé: Immunol Allergy Clin North Am
Pays: United States
ID NLM: 8805635
Informations de publication
Date de publication:
May 2024
May 2024
Historique:
medline:
5
4
2024
pubmed:
5
4
2024
entrez:
4
4
2024
Statut:
ppublish
Résumé
Adult patients with eosinophilic esophagitis (EoE) typically present with a history of dysphagia for solids, sometimes with additional reflux-like pain and a history of prior food impactions. In contrast to these alarming symptoms, the general appearance and physical examination of adult patients with EoE is in line with apparently healthy individuals. Therefore, the diagnosis is based on a history of solid-food dysphagia and eosinophilic tissue infiltration. Importantly, the increasing prevalence of EoE variants, that is, typical EoE symptoms in the absence of a relevant eosinophilia, and several studies with eosinophil-targeting drugs, call the pathogenic role of eosinophils into question.
Identifiants
pubmed: 38575217
pii: S0889-8561(23)00109-1
doi: 10.1016/j.iac.2023.12.006
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
185-196Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure L. Biedermann has consulting contracts with Abbvie, BMS, MSD, Vifor, Falk, Esocap, Calypso, Ferring, Pfizer, Takeda, Janssen, Sanofi. A. Straumann has consulting contracts with Astra-Zeneca, BMS, Calypso, EsoCap, Falk Pharma, GSK and Sanofi.